论文部分内容阅读
宫颈癌是全球最致命但也是最容易预防的女性癌症类型,人乳头瘤病毒(HPV)感染是罪魁祸首,导致了99%的宫颈癌病例,其中2种基因型(HPV-16/18)占到了70%。接种疫苗是预防宫颈癌的一种有效手段,当前宫颈癌疫苗的免疫程序通常为2针(0,6个月)或者3针(0,1,6个月)。然而令人担忧的现实情况是,有相当多的年轻女性并没有按规定及时地完成2针或3针注注射。这是否会降低疫苗预防HPV感染的效果呢?近日,来自美国路易斯维尔大学(UL)的研究人员,对宫颈癌疫苗Cervarix(HPV16/18 AS04)2个大规模
Cervical cancer is the most deadly but most preventable type of cancer in the world. Human papillomavirus (HPV) infection is the culprit, resulting in 99% of cervical cancer cases, of which 2 genotypes (HPV-16/18) To 70%. Vaccination is an effective means of preventing cervical cancer. The current immunization schedule for cervical cancer vaccines is usually 2-pin (0,6 months) or 3-pin (0,1,6 months). However, the worrying fact is that a considerable number of young women did not complete the 2-or 3-needle injection in a timely manner as required. Will this reduce the effectiveness of the vaccine in preventing HPV infection? Recently, researchers from the University of Louisville (UL) of the United States conducted a survey of two large-scale cervical cancer vaccine Cervarix (HPV16 / 18 AS04)